Following a dramatic mid-air incident on an Air India flight from Phuket to Delhi where a brief hydraulic failure caused a sudden 300-foot drop, aviation safety has come under intense scrutiny. While technical glitches happen, post-incident protocols revealed a “non-negative” psychoactive substance test for the flight’s captain. Although investigators have not linked the drug test result to the technical failure, India’s Directorate General of Civil Aviation (DGCA) is taking zero chances. The regulator has mandated a comprehensive one-time drug screening for nearly 14,000 pilots across the nation by July 2027, pushing aviation safety protocols into a stricter era.
Altitude and Attitude: How DGCA Makes Sure High-Flying Pilots Don’t Fly High
If you enjoyed reading this article, you can help support our journalism by adding OHeraldo as a preferred source.
There is something inherently unsettling about flying. Thirty thousand feet above the ground, hundreds of passengers sit inside a pressurized metal tube traveling at hundreds of kilometers per hour, trusting a handful of people with their lives. Yet every day, millions make this decision without thinking twice. When an incident occurs, it naturally raises questions about the systems keeping those cockpits safe.
The Phuket-Delhi Flight Upset
On August 4, an Air India A320 flying from Phuket to Delhi was cruising at 36,000 feet when it suddenly climbed 372 feet before dropping nearly 300 feet. Twenty-four people on board sustained injuries due to the sudden movement, with four requiring extended hospitalization.
Preliminary findings by the Aircraft Accident Investigation Bureau (AAIB) indicated that over an eight-second window, the aircraft suffered a temporary, simultaneous loss of all three hydraulic systems, causing the autopilot to disengage. Although system pressure recovered within seconds and the flight landed safely, standard post-incident procedures triggered routine screening for both pilots.
‘Non-Negative’ Screening and the Regulatory Lens
While the co-pilot tested negative, the pilot-in-command returned a “non-negative” result for a psychoactive substance during initial and laboratory confirmatory testing. Aviation investigators clarified that the test result did not prove operational impairment or cause the mechanical failure. Nonetheless, the AAIB flagged substance screening as a serious concern, prompting immediate regulatory review. Air India subsequently terminated the captain under its zero-tolerance policy.
Understanding the DGCA Safety Net
Being fit to fly is a strict regulatory mandate. The DGCA has long enforced breathalyzer testing for alcohol under Rule 24 of the Aircraft Rules, 1937, covering flight and cabin crew prior to departure or post-landing on international arrivals.
Psychoactive substance testing—introduced more recently—follows a structured, two-part protocol:
- Initial & Confirmatory Sampling: Urine samples are split into A and B portions. A positive A-sample screening requires confirmatory lab analysis of the B-sample before official action is taken.
- Rehabilitation vs. Cancellation: The system accounts for medical exceptions (such as prescribed medications). First-time confirmed offenses require mandatory rehabilitation and psychiatric clearance before return to duty. A repeated infraction results in license cancellation.
Widening the Net Across Indian Aviation
To ensure absolute safety, the DGCA has directed all Indian airlines to conduct a mandatory, one-time drug test for their nearly 14,000 pilots by July 2027. Concurrently, the regulator is finalizing revised Civil Aviation Requirements (CAR) to make random testing protocols even more stringent.
While job pressures, long hours, and high stress are reality for flight crews, regulators and pilots agree that cockpit safety remains paramount. Ultimately, rules and testing act as crucial guardrails, but the final line of defense rests with the professionals trusted at the controls.
